Division of respirology, critical care and sleep medicine

DIVISION OF RESPIROLOGY,
CRITICAL CARE,
AND SLEEP MEDICINE
2007 – 2008
ANNUAL REPORT
Department of Medicine
University of Saskatchewan and
Saskatoon Health Region
Table of Contents
Introduction …………………………………………………………………….Page 3 Division Faculty ……………………………………………………………….Page 3 Division Personnel ……………………………………………………….….Page 4 Research and Scholarly Activity …………………………………………Page 5 Teaching and Professional Learning …………………….…………….Page 17 Clinical Services and Activity …………………………………………… Page 19 Administration and Leadership ………………………….…………… Page 20 The Division of Respirology, Critical Care, and Sleep Medicine resides in the Department of Medicine at the College of Medicine, University of Saskatchewan, and the Saskatoon Health Region. The Division’s mandate includes provision of clinical services and patient care in the inpatient and outpatient settings, teaching and professional learning, research and scholarly activities, and administration and leadership. The Division of Respirology, Critical Care and Sleep Medicine has ten full-time members, seven of whom practice Respirology, three whom practice Critical Care Medicine along with Respirology, four whom specialize in Sleep-Disordered Breathing along with Respirology, and two whom are PhD’s. Dr. Hurst is a Professor Emeritus, after having retired from the University in 2007. The Division has a Royal College of Physicians and Surgeons of Canada certified Subspecialty Training Program in Respirology, and in addition, plays an integral role in both undergraduate and postgraduate teaching in the College of Medicine at the University of Saskatchewan. The Division provides a multitude of essential clinical programs, and directs numerous clinical laboratories in the Saskatoon Health Region. Many of these clinical programs and laboratories are provincial resources and unique to Saskatchewan. In addition to the provision of clinical care and teaching, the Division also undertakes, supervises and participates in a number of active research programs. Division members collaborate with interprofessional colleagues and other investigators in the College of Medicine and at the University of Saskatchewan, and also with research colleagues based at various academic institutions in Canada and elsewhere. The following represents a summary of Division resources, capabilities and activities in 2007-2008. DIVISION FACULTY

FULL-TIME MEMBERS:
D.D. Marciniuk, MD, FRCP(C), FCCP
Appointment to University of Saskatchewan: 1990 D.W. Cockcroft, MD, FRCP(C), FCCP
Appointment to University of Saskatchewan: 1977 D.J. Cotton, MD, FRCP(C), FCCP
Appointment to University of Saskatchewan: 1976 J.A. Gjevre, MD, FRCP(C), FCCP
Appointment to University of Saskatchewan: 2002 J.R. Gordon, PhD, BSc(Adv)
Appointment to University of Saskatchewan: 1991 B.L. Graham, PhD, P.Eng
Appointment to University of Saskatchewan: 1977 T.S. Hurst, MVetSc, FCCP
Appointment to University of Saskatchewan: 1987 K.F. Laframboise, MD, FRCP(C), FCCP
Appointment to University of Saskatchewan: 1997 J.K. Reid, MD, FRCP(C), D.ABSM
Appointment to University of Saskatchewan: 2003 R.P. Skomro, MD, FRCP(C), D.ABSM, FCCP
Appointment to University of Saskatchewan: 1998
ASSOCIATE MEMBER:
S.J. Butcher, MSc, PhD.
Assistant Professor, School of Physical Therapy Appointment to University of Saskatchewan: 2007
RESPIROLOGY FELLOWS:
C. Pierce, MD, FRCP(C)
B. Dang, MD, FRCP(C)
C. Illamperuma, MD, FRCP(C)

AFFILIATED MEMBERS:
R. Abdulla, MD, FRCP(C)
K. Gowda, MD, FRCP(C)
R. Hafezi, MD, FRCP(C)
V. Hoeppner, MD, FRCP(C)
N. Joanis, MD, FRCP(C)
A. Muftah, MD, FRCP(C)
R. Patel, MD, FRCP(C)
G. Sridhar, MD, FRCP(C)
M. Ubhi, MD, FRCP(C)
H. Ward, MD, FRCP(C)
DIVISION PERSONNEL

ADMINISTRATIVE STAFF:
Jacquie Bramley
Julie Hunter
Candace Leuschen
Brenda McLaren
Jennifer Martin
Angela Reimer
Agnes Ross

RESEARCH STAFF:
Janet Baran, RN
Funded by Member Research Funds (Marciniuk) Ron Clemens 1.0
Beth Davis, BSc
Funded by Member Research Funds (Cockcroft) Maryla Stiles
Funded by Member Research Funds (Skomro/Reid)
NURSE CLINICIANS:
Niki Afseth, RN, BScN
Maureen Harrison, RN
Shelly Hutchison, RN, BScN
Tracy Kabaroff, RN, BScN
Vicki Kennedy, RN, BScN
Lori Johnston, RN, BScN

OTHER PERSONNEL AFFILIATIONS:
• Pulmonary Function and Cardiopulmonary Exercise Testing Laboratory staff at Royal University Hospital, Saskatoon City Hospital and St. Paul’s Hospital • Saskatoon Sleep Laboratory Staff at Royal University Hospital • Pulmonary Rehabilitation Program Staff in the Saskatoon District Health Region (Saskatoon Field House, Confederation Park Mall, and Humboldt)
ASSOCIATE MEMBERSHIPS:
Cockcroft DW
Associate Member, Department of Physiology, 1997 to present. Associate Member, Department of Pharmacology, 2002 to present. Graham BL
Associate Member, College of Graduate Studies, 1980 to present. Associate Member, Biomedical Engineering, 1977 to present. RESEARCH AND SCHOLARLY ACTIVITY

HONOURS AND AWARDS:
Gordon JR
Elected to Membership, Collegium Internationale Allergologicum, May Marciniuk DD
Lung Association of Saskatchewan COPD Professorship, 2007 to 2008, $50,000 (new application/new award). Skomro RP
Lung Association of Saskatchewan Sleep Apnea Professorship, 2007 to 2008, $35,000 (new application/new award). PUBLICATIONS:

Allen ND, Davis BE, Cockcroft DW. Correlation between airway inflammation and loss of deep inhalation
bronchoprotection in asthma. Annals of Allergy, Asthma and Immunology 2008; in press.
Alves R, Resende MB, Skomro R, Souza FJ, Reed UC. Sleep and neuromuscular disorders in children.
Sleep Medicine Review 2008; June 3 (Epub); doi:10,1016/j.smrv.2008.02.002.
Andersen M, Poyares D, Alves R, Skomro R, Tufik S. Sexsomnia: atypical sexual behavior during sleep.
Brain Research Review 2007; 56:271-282.
Boulet L-P, Gauvreau G, Boulay M-E, O’Byrne P, Cockcroft DW. The allergen bronchoprovocation model:
An important tool for the investigation of new asthma anti-inflammatory therapies. Allergy 2007; 10:1101-
1110.
Boulet L-P, McIvor A, Marciniuk DD, on behalf of Canadian Thoracic Society Respiratory Guidelines
Committee. Invited Editorial: Respiratory Guidelines Implementation in Canada. Canadian Respiratory
Journal 2007; 329-330.
Cheng H-T, Huang K-C, Yu H-Y, Gao K-J, Zhao X, Li F, Town J, Gordon JR, Cheng J-W. A new protocol
for high-yield purification of recombinant human CXCL8(3–72)K11R/G31P expressed in Escherichia coli.
Protein Expression and Purification 2008; in press.
Chura R, Butcher SJ, Marciniuk DD. Exercise Recommendations for Patients with Chronic Obstructive
Pulmonary Disease. Current Issues in Cardiac Rehabilitation and Prevention 2008; 16(1):1-5.

Cintra F, Poyares D, Rizzi CF, Risso TT, Skomro R, Montuori E, Mello-Fujita L, de Palol A, Tufik S.
Cardiorespiratory Response to Exercise in Men and Women with Obstructive Sleep Apnea. Sleep Medicine
2008 August 13 (Epub); doi:10.1016/j.sleep.2008.042.006.

Cockcroft DW, Davis BE. Extrapolation of allergen PC15. Annals of Allergy, Asthma and Immunology
2008; 100:619-620.
Duong M, Cockcroft DW, Boulet L-P, Ahmed T, Iverson H, Atkinson CD, Stahl EG, Watson R, Davis B,
Milot J, Gauvreau GM, O’Byrne PM. The effect of IVX-0142, a heparin-derived hypersulfated disaccharide,
on the allergic airway responses in asthma. Allergy 2008; in press.
Fenton ME, Kanthan R, Cockcroft DW. Nitrofurantoin-associated bronchiolitis obliterans organizing
pneumonia: report of a case. Canadian Respiratory Journal 2008; in press.

Fenton ME, Cockcroft DW, Wright JL, Churg A. Hypersensitivity pneumonitis as a cause of airway-
centered interstitial fibrosis. Annals of Allergy, Asthma and Immunology 2007; 99:465-466.
Fenton M, Cockcroft DW, Gjevre JA. Intracerebral Abscess: A complication of severe cystic fibrosis lung
disease. Canadian Respiratory Journal 2008; 15(1):45-47.
Gauvreau G, Boulet L-P, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K,
Duong M, Watson RM, Renzi PM, O’Byrne PM. Antisense therapy against CCR3 and the common beta
chain attenuates allergen-induced eosinophilic responses. American Journal of Respiratory and Critical
Care Medicine 2008; 177:932-958.
Klomp H, Lawson JA, Cockcroft DW, Chan BT, Cascagnette P, Gander L, Jorgenson D. Examination of
asthma quality of care using Saskatchewan health care administrative databases. Canadian Medical
Association Journal 2008; 178:1013-1021.
Lem JJ, Kozyrskyj AL, Cockcroft DW, Becker AB. Diagnosing asthma in children: what is the role for
methacholine bronchoprovocation testing? Paediatric Pulmonology 2008; 43:481-489.

Marciniuk DD. Cardiopulmonary Exercise Testing. Best of the Web Review, American Thoracic Society,
February 2008. )
Marciniuk DD. Time to Reflect. Editorial. Canadian Respiratory Journal 2007; 14:457-459.
Marciniuk DD. Don’t Believe Anyone Who Says Smoking Won’t Kill You. Ottawa Citizen, November 12,
2007; A15.
Marciniuk DD. A Breath of Fresh Air. Editorial. Canadian Respiratory Journal 2007; 14:379-380.

Marciniuk DD. Healthy Relationships and Respiratory Health. Editorial. Canadian Respiratory Journal
2007; 14:322-324.
Marciniuk DD. It is Time to Become a Member of The Canadian Thoracic Society. Editorial. Canadian
Respiratory Journal 2007; 14:261-263.
Marciniuk DD, Butcher SJ, Reid JK, McDonald GF, Eves ND, Clemens RE, Jones RL. Helium-Oxygen


Marciniuk DD, Butcher SJ. Invited Letter to the Editor: “There Is No Magic Bullet in COPD”. Journal of
Applied Physiology 2008:
Podechard N, Lecureur V, Leferrec E, Guenon I, Sparfel L, Gilot D, Gordon JR, Lagente V, Fardel O.
Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-
dependent and leads to lung inflammation. Toxicology Letters 2007; 177:130.
Rennie DC, Lawson JA, Kirychuk SP, Paterson C, Willson P, Senthilselvan A, Cockcroft DW, McDuffie HH.
Assessment of the relationship between endotoxin and current asthma and wheeze in a case control study
of school age children. Indoor Air 2008; in press.
Silva RS, Truksinas V, de Mello-Fujita L, Truksinas E, Zanin LK, Ribeiro Pinto MC, de Paula MS, Skomro R,
Rita L, Bittencourt A, and Tufik S. An orientation session improves objective sleep quality and mask
acceptance during positive airway pressure titration. Sleep and Breathing 2008; 12(1):85-89.
Skomro R. Sleep and Quality of Life in Diabetes. In: Sleep and Quality of Life in Medical Illness. Verster J,
et al, Chapter 48; Pg 461- 468. Humana Press, New Jersey, USA, 2008.
Skomro R, Silva RS, Alves R, Figueiredo A, Lorenzi-Filho G. The Prevalence and Significance of Periodic
Leg Movements in Patients with Congestive Heart Failure. Sleep and Breathing 2008; in press.
Skomro R, Cotton DJ, Gjevre JA, Grover V, McNab BD, Reid JK, Ward HA. An Empirical CPAP trial for
Suspected Obstructive Sleep Apnea Syndrome (OSAS). Canadian Respiratory Journal 2007; 14(3):151-
163.
Wang H, Meng QH, Gordon JR, Khandwala H, & Wu L. Proinflammatory and proapoptotic effects of
methylglyoxal on neutrophils from Type-2 diabetic patients. Clinical Biochemistry 2007; 40:1232-1239.
Zhao X, Li F, Town JR, Zhang X, Wang W, Gordon JR. Humanized forms of the CXCR1/CXCR2
antagonist, bovine CXCL8(3-74)K11R/G31P, effectively block ELR-CXC chemokine activity and airway
endotoxemia pathology. International Immunopharmacology 2007; 7:1723-31.
CONFERENCE PROCEEDINGS AND ABSTRACTS:

Allen ND, Davis BE, Cockcroft DW. Correlation between airway inflammation and loss of deep inhalation
bronchoprotection in asthmatics (abstract). European Respiratory Journal 2007; 30(Suppl 51):E1893.
Boulet LP, Gauvreau GM, Cockcroft DW, Deschesnes F, Renzi PM, O’Byrne PM. Effects of ASM8 on
allergen-induced responses in humans. American Journal of Respiratory and Critical Care Medicine 2007;
175:A56.
Gauvreau GM, Boulet LP, Cockcroft DW, Duong M, D’Anjou HD, Renzi PM, O’Byrne PM.
Pharmacological effects of ASM8, an antisense oligonucleotide to CCR3 and the common beta
chain receptor in mild asthmatics. Journal of Allergy and Clinical Immunology 2007; 119:S46.
Goodridge DM, Lawson J, Marciniuk DD, Rennie D, Duggleby WD. End of Life Care Quality for
Patients with COPD and Lung Cancer: Hospital Days in the Last 12 Months of Life and Place of
Death. American Journal of Respiratory and Critical Care Medicine 2008; 177:A829.
Huang H, Zhang X, Town J, Gordon JR. Tolerogenic dendritic cell treatments activate infectious
tolerance pathways. Both CD4+CD25+Foxp3+ T cells and dendritic cells from the lungs of
treated mice express a tolerogenic phenotype. International Congress of Immunology, Rio de
Janiero, Brazil, August 2007.
Huang H, Zhang X, Town J, Gordon JR. Tolerogenic dendritic cells activate infectious tolerance
pathways via inducing the development of regulatory dc and cd4+cd25+foxp3+ t cells. Annual
Meeting of the Canadian Society for Immunology, Mount. Tremblant, Quebec, April 11-14, 2008.
Mayers I, Jacobs P, Marciniuk DD, Chuck A. Combination Therapy (Long Acting Beta Agonists
(LABA) plus Corticosteroids) Versus LABA Alone for Chronic Obstructive Pulmonary Disease
(COPD): An Economic Analysis. American Journal of Respiratory and Critical Care Medicine 2008;
177:A652.
O’Byrne PM, van der Linde J, Boulet L-P, Cockcroft DW, Fitzgerald JM, Gauvreau GM, Hart L,
Korducki L, Brannan JD, Hamilton A. Single doses of BI 1744 CL, a novel long-acting β2-agonist,
are effective for up to 32 hrs in asthmatic patients. American Journal of Respiratory and Critical Care Medicine 2008; 177:A611. Reid J, Olatunbosun F, Gjevre JA, Skomro R, Cotton D, Stiles M, McNab BD. Continuous
Electronic Fetal Heart Rate Monitoring of Pregnant Women During Overnight Polysomnography.
American College of Chest Physicians Congress, Chicago, Il, USA, pg 648S, Published October
2007.
Shaw SA, Macala K, Ward HA, Reid JK. Hyperglycemia is common in patients following discharge
from the ICU. Critical Care Medicine 2007; 35:592A.
Skomro R, Cotton D, Reid JK, Gjevre JA, McNab BD, Ward HA, Stiles M, Jokic R, Grover V. Quality of
life of OSA subjects diagnosed and treated at home. Sleep 2007; 30:A163.
Skomro R, Reid JK, Gjevre JA, Ward HA, Jokic R, Stiles M, Cotton D. Randomized Trial of Home-
Based vs. In-Lab Management of OSA. American Journal of Respiratory and Critical Care Medicine 2008;
177:(Suppl)A803.
Tallon N, Reid JK, Olatunbosun F, Martel J, Ward HA. Obstetric patients admitted to the critical care unit:
a nine year review from a Canadian tertiary care hospital. Journal of Obstetrics and Gynecology of Canada
2008;30(5) S18. O-OBS-JM-018.
Town J, Li W, Gordon JR. Highly Effective Blockade of Melanoma Tumour Metastasis by ELR-CXC
Chemokine Antagonism. Annual Meeting of the Canadian Society for Immunology, Mount. Tremblant,
Quebec, April 11-14, 2008.
Webb KA, Marciniuk DD, Hernandez P, Hamilton R, Weisman I, Clemens R, Baran J, Preston M,
O’Donnell DE. Refining the Constant-Load Cycle Exercise Endurance Test in COPD. American Journal of
Respiratory and Critical Care Medicine 2008; 177:A999.
Zhao X, Town J, Zhang X, Gordon JR. ELR (Glu-Leu-Arg) + CXC Chemokine Antagonist Targets
Neutrophilic Pathology at Multiple Levels. Annual meeting of the Canadian Society for Immunology, Mount
Tremblant, Quebec, April 11-14, 2008.
Zhao X, Town J, Zhang X, and Gordon JR. ELR+CXC Chemokine Antagonism Targets Neutrophilic
Pathology at Multiple Levels. Experimental Biology 2008. San Diego, April 5-9, 2008.
INVITED LECTURES AND CONFERENCE PRESENTATIONS (EXTERNAL):
(49 in 2007-2008: 15 Local/Provincial, 17 National, and 17 International)
Cockcroft DW:

Invited Speaker, “Methacholine Challenge: A Tale of Two Methods”. CSPS Annual Meeting, Banff,
Alberta, May 24, 2008.
Invited Speaker, “Exercise-induced Hyperventilation”. Saskatoon Allergy Group, Saskatoon,
Saskatchewan, May 20, 2008.
Invited Speaker, “Alphabet Soup Asthma Studies”. ASTHMATREK Telehealth Presentation to Asthma
Educators in Western Canada, Saskatoon, Saskatchewan, April 17, 2008.

Pro/Con Debate: Direct Challenge is Better than Indirect for Asthma Diagnosis – PRO. AAAAI Meeting,
Philadelphia, Pennsylvania, March 14-18, 2008.
Invited Speaker, “Direct and Indirect Challenges: Methacholine and Allergen”. AAAAI Meeting,
Philadelphia, Pennsylvania, March 14-18, 2008.
Instructor, Interpretation of Pulmonary Function Tests. AAAAI Meeting, Philadelphia, Pennsylvania, M
March 14-18, 2008.
Invited Speaker, “Bronchial Hyperresponsiveness to Pharmacological Bronchoconstriction in the
Diagnosis and Control of Asthma. Direct or Indirect Agonist: Direct”. Symposium – Controversies and
New Findings in Allergy (4th edition), Madrid, Spain, February 1-2, 2008.
Co-chair, Current Issues in Airway Physiology, Pharmacology and Monitoring. European Respiratory
Society Annual Meeting, Stockholm, Sweden, September 14-19, 2008.

Gordon JR:
Invited Speaker, “Neutrophil Antagonism as a Therapeutic Approach in Cystic Fibrosis”. Annual Meeting of
the Saskatchewan Chapter of the Canadian Cystic Fibrosis Foundation, January 28, 2008.
Invited Speaker, “Interleukin-10-Differentiated Human Dendritic Cells Tolerize Th2 Responses of Atopic
Subjects by Inducing the Differentiation of Regulatory T Cells”. 2008 Meeting of the Collegium
Internationale Allergologicum, Curacao, Netherland Antilles, May 5, 2008.
Invited Speaker, “CXCL8(3-73)K11R/G31P, A Novel Neutrophil Antagonist”. Advent Healthcare Ventures.
Boston, Massachusetts, May 22, 2008.

Laframboise KL:

Invited Speaker, “Pulmonary Arterial Hypertension: Who is this New Kid on the Block?” The Canadian
Society of Respiratory Therapists National Respiratory Therapy Conference and Trade Show, Saskatoon,
Saskatchewan, May 23, 2008.
Invited Speaker, “Primary Pulmonary Hypertension”. Saskatoon Health Region “Medley of Today’s Acute
Care – A Multidisciplinary Conference”, Saskatoon, Saskatchewan, January 25, 2008.

Marciniuk DD:

Invited Speaker, “Towards a Framework for Respiratory Health”. Canadian Respiratory Congress,
Montreal, Quebec, June 21, 2008.
Chair, Satellite Symposia, “Tobacco Addiction Treatment: What’s The Buzz”. Canadian Respiratory
Congress, Montreal, Quebec, June 21, 2008.
Invited Speaker, “Assessing Activity Limitation in COPD”. Canadian Respiratory Congress, Montreal,
Quebec, June 20, 2008.
Chair, Scientific Session, “Assessment and Management of Exercise in COPD”. Canadian Respiratory Congress, Montreal, Quebec, June 20, 2008. Speaker, “The LiveWell Model”, Continuing Professional Learning, Saskatoon, Saskatchewan, June 9, 2008. Co-Chair, “Exercise and Exercise Training in Health and Disease”. Poster Discussion Session. American Thoracic Society 2008 International Conference, Toronto, Ontario, May 21, 2008. Chair, “Cardiopulmonary Exercise Testing for the Practicing Clinician - Putting Advances Into Practice” Postgraduate Exercise Course, American Thoracic Society 2008 International Conference, Toronto, Ontario, May 16, 2008 ($500 US Registration Fee - 83 registrants). Speaker, “Case Studies - Interstitial Lung Disease” in Cardiopulmonary Exercise Testing for the Practicing Clinician - Putting Advances Into Practice” Postgraduate Exercise Course, American Thoracic Society 2008 International Conference, Toronto, Ontario, May 16, 2008. Speaker, “Clinical Implementation of the 2008 COPD Recommendations”. Continuing Professional Learning, Saskatoon, Saskatchewan, May 6, 2008. Invited Speaker (Visiting Professor), “Royal College Respirology Examination Preparation”. Division of Respirology, McMaster University, Hamilton, Ontario, April 29, 2008. Invited Speaker (Visiting Professor), “COPD: More Than Just the Cookbook”. Firestone Institute of Respiratory Health, McMaster University, Hamilton, Ontario, April 29, 2008. Speaker, “COPD: A Matter of Life and Breath – From Diagnosis to the Latest Discoveries”. Continuing Professional Learning, Saskatoon, Saskatchewan, April 21, 2008. Speaker, “Implementing the 2008 COPD CTS Recommendations”. Continuing Professional Learning, Saskatoon, Saskatchewan, April 15, 2008. Invited Speaker, “2008 COPD Update – Symposia Pneumonology”. Continuing Professional Learning, Saskatoon, Saskatchewan, March 12, 2008. Invited Speaker, “COPD Guidelines Update 2008”. Continuing Professional Learning, Saskatoon, Saskatchewan, March 12, 2008. Invited Speaker, “End of Life Issues in COPD”. British Columbia Interior Health COPD Collaborative, Kelowna, British Columbia, March 11, 2008. Invited Speaker, “COPD Literature Review – What Will Change My Practice”. Kelowna and District Respirology Group, Continuing Professional Learning, Kelowna, British Columbia, March 10, 2008. Invited Speaker, “Pearls from the Canadian Thoracic Society COPD Guidelines”. Saskatchewan Association of Pharmacists Conference, Continuing Professional Education, Saskatoon, Saskatchewan, March 1, 2008 (66 attendees). Invited Keynote Speaker, “Exercise Testing: What’s Important for the Clinician.” 17th Annual British Columbia Thoracic Society and Society for Allergy and Immunology Conference, Vancouver, British
Columbia, January 19, 2008.
Invited Keynote Speaker, “Learnings from the 2007 Canadian Thoracic Society COPD Guidelines”. 17th
Annual British Columbia Thoracic Society and Society for Allergy and Immunology Conference,
Vancouver, British Columbia, January 19, 2008.
Invited Speaker, “Exercise Limitation in COPD: The Effects of Altering Inspired Gas”. iCapture Center
for Cardiovascular and Pulmonary Research, St. Paul’s Hospital, Vancouver, British Columbia, January
18, 2008.
Invited Speaker, “Patient-Centered COPD Management”. Continuing Professional Learning, North
Battleford, Saskatchewan, November 28, 2007.
Invited Speaker, “Non-Pharmacologic Management of COPD”, American College of Chest Physicians
2007 International Conference, Chicago, Illinois, October 24, 2007. Presentation Highlighted in
Pulmonary Reviews: “What Does Current Research Say About COPD Treatment Options?”, January 18,
2008.
Chair, “Exercise Testing in COPD: From Bench to Bedside”. American College of Chest Physicians
2007 Annual Meeting, Chicago, Illinois, October 24, 2007.
Moderator, Abstract Poster Presentations, “Physiology, Pulmonary Function Testing, Rehabilitation”.
American College of Chest Physicians 2007 Annual Meeting, Chicago, Illinois, October 24, 2007.
Invited Speaker, “How Does Exercise Testing Assist Patient Care?” American College of Chest
Physicians 2007 International Conference, Chicago, Illinois, October 23, 2007.
Moderator, Abstract Slide Presentations, “CAP and HAP”. American College of Chest Physicians 2007
Annual Conference, Chicago, Illinois, October 23, 2007.
Invited Speaker, “Update on Cardiopulmonary Exercise Testing”. Division of Respiratory Medicine,
Windsor General Hospital, Windsor, Ontario, October 1, 2007.
Invited Speaker, “COPD and Disability”. Canadian Pension Plan Appeals Board Annual Meeting,
Victoria, British Columbia, July 24, 2007.
Reid JK:
Invited Speaker, “Evaluation of Chronic Cough”. Common Medical Problems Management Seminar,
Saskatoon, Saskatchewan, November 2008.

Invited Speaker, “Sleep Disordered Breathing and Gestational Hypertension”. Sleep Apnea Support
Group meeting, Saskatoon, Saskatchewan, September 2008.
Skomro RP:

Invited Speaker, “Sleep Lab Protocols”. Sleep Disorders Center Education Day, Royal University
Hospital, Saskatoon, Saskatchewan, April 18, 2008.
Invited Speaker, “COPD Review”. College of Medicine Continuing Professional Learning, Rosetown, Saskatchewan, March 2008. Invited Speaker, “Diagnosis of OSA”. Warsaw Medical University Sleep Medicine Rounds, Warsaw, Poland, October 3, 2007. Invited Speaker, “In-home Diagnosis and Management of OSA. Global Perspectives on Chronic Disease. World Health Organization Conference, Calgary, Alberta, October 30, 2007.
Invited Speaker, “An Update on Sleep Apnea”. Practical Management of Common Medical Problems.
Division of Continuing Professional Learning, College of Medicine, University of Saskatchewan,
November 23, 2007.
PATENTS GRANTED OR PENDING:
(2 in 2007-2008)

Gordon JR:
US Patent office provisional patent No. 61/027,959 (ELR-CXC chemokine antagonism operates at
multiple levels). Filed February 12, 2008. John R. Gordon, inventor.
US Patent office provisional patent No. 61/043,573 (ELR-CXC chemokine antagonism in aspiration
pneumonia and melanoma tumour metastasis). Filed April 9, 2008. John R. Gordon, Xixing Zhao and
Jennifer Town, inventors.
RESEARCH GRANTS AND FUNDING:
($2,585,661 awarded in 2007-2008 as Primary or Co-Investigators/Applicants)
Cockcroft DW:
AllerGen (NCE Centres of Excellence) CIC establishment award, 2007 to 2008, $70,000. PEER
REVIEWED

Randomized double-blind, placebo-controlled, paral el-group study to assess the efficacy and safety of
4 weeks once daily administration of orally inhaled BI1744CL (2 μg, 5 μg, 10 μg, 20 μg) delivered by
the Respimat® inhaler in patients with asthma. Principal Site Investigator – Dr. Paul M. O’Byrne (Dr.
D.W. Cockcroft is co-investigator). Boehringer-Ingelheim – $11,500 per subject (approx.) x 10 (est.).
NON-PEER REVIEWED

Phase II multi-centre, randomized, double-blind, parallel-group, placebo-controlled study to evaluate
the efficacy and safety of lyophilized and aged liquid Omalizumab in the prevention of allergen-induced
airway obstruction in adults with mild allergic asthma (AQUA). Principal Site Investigator – Dr. D. W.
Cockcroft. Genentech Inc. - $26,000 per patient (approx.) x 10 (est.). AllerGen CIC industry
collaboration. NON-PEER REVIEWED

Gjevre JA:
Canadian Cystic Fibrosis Foundation – Adult CF Clinic, University of Saskatchewan, 2008: $26,000.
PEER REVIEWED
Gordon JR:
Mechanisms mediating tolerogenic dendritic cell therapy in allergic asthma. Canadian Institute of
Health Research Operating Grant, 2008 to 2013, $645,000. PEER REVIEWED
ELR-CXC chemokines in bacterial inflammation. NSERC Discovery Grant, 2008 to 2009, $29,000.
PEER REVIEWED

AllerGen NCE strategic funds grant. Canadian Group on Food Allergy Research (CanGoFAR). Co-
Investigator: Dr. John R. Gordon (Principal Investigator is Dr. J. Marshall with 8 Co-Applicants), 2007
to 2009, $740,000. PEER REVIEWED

The response of the equine temporomandibular joint to short term inflammation as compared to that
of the fetlock joint. Co-Investigator: Dr. John R. Gordon (Principal Investigator is Dr. J. Carmalt).
Equine Health Research Fund, 2007 to 2008, $10,700. PEER REVIEWED
Marciniuk DD:
Optimizing Exercise Rehabilitation in Patients with COPD. Co-Investigator: Dr. Darcy D. Marciniuk
(Principal Investigator is Dr. Scott Butcher, School of Physical Therapy, University of Saskatchewan).
Canadian Lung Association/Canadian Respiratory Health Professionals, September 1, 2008 to August
31, 2009, $19,690.00. PEER-REVIEWED
Care Transition Outcomes for People with Advanced COPD. Co-Investigator: Dr. Darcy D. Marciniuk
(Principal Investigator is Dr. Donna Goodridge). Canadian Lung Association/Canadian Respiratory
Health Professionals, September 1, 2008 to August 31, 2009, $20,255. PEER-REVIEWED
High-Intensity Exercise and Ventilatory Limitations in Chronic Obstructive Pulmonary Disease (COPD):
Effect of Interval Exercise and Breathing Helium-Hyperoxia on Acute Exercise Performance.
Saskatchewan Health Research Foundation New Investigator Establishment Grant. Co-Investigator:
Dr. Darcy D. Marciniuk (Principal Investigator is Dr. Scott Butcher, School of Physical Therapy,
University of Saskatchewan). Saskatchewan Health Research Foundation, July 1, 2008 to June 30,
2010, $110,000. PEER-REVIEWED
The Relationship Between Quadriceps Muscle Strength, Power, and Functional Performance in COPD.
Co-Investigator: Dr. Darcy D. Marciniuk (Principal Investigator is Dr. Scott Butcher, School of Physical
Therapy, University of Saskatchewan). Royal University Hospital Foundation Research Fund,
Saskatoon, Saskatchewan, April 1, 2008 to March 31, 2009, $25,000. PEER-REVIEWED
Respiratory Population-Based Outcomes Network: Studies and Evaluations (RESPONSE). Co-
Investigator: Dr. Darcy D. Marciniuk (Drs. Teresa To and Nancy Garvey, Toronto Hospital for Sick
Children are Principal Investigators). Canadian Institutes of Health Research 2007 Partnerships for
Health System Improvement Grant, September 2007 to September 2010, $150,000. PEER-
REVIEWED
A 24-Week (+24 Week Extension), Randomized, Placebo-Controlled (Only 1st 12-Week Period),
Double-Blind, Parallel–Group, Efficacy and Safety Comparison of Tiotropium/Salmeterol (7.5 ug /25 ug)
Inhalation Powder in the Morning (PE Capsule Via Tiotropium/Salmeterol HandiHaler®), Tiotropium
(18 ug) Inhalation Powder in the Morning (Gelatine Capsule Via Spiriva® HandiHaler®), Salmeterol
Inhalation (25 ug) Powder in the Morning and Evening (PE Capsule Via Tiotropium/Salmeterol
HandiHaler®) and Tiotropium/Salmeterol (7.5 ug/25 ug) Inhalation Powder in the Morning (PE
Capsule Via Tiotropium/Salmeterol HandiHaler®)Plus Salmeterol (25 ug) Inhalation Powder in the
Evening (PE Capsule Via Tiotropium/Salmeterol HandiHaler®) in Patients with COPD. Lead
International Study Coordinator: Dr. Darcy D. Marciniuk (Dr. John Reid is Site Co-Investigator).
Boehringer Ingelheim Canada, June 2008 to February 2010, $124,275. NON-PEER REVIEWED
(Overall International Study Coordinator Involved in the Synthesis, Design, Conduct, Analysis and
Publication of this Phase IIIa Trial).

Randomized, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks of Once
Daily Treatment of 3 Doses of Orally Inhaled BI 1744.CL, Each in Fixed Dose Combination with 5 ug
Tiotropium Bromide (Delivered by the Respimat® Inhaler ) Compared with 5 ug Tiotropium Bromide
Monoproduct (Delivered by the Respimat® Inhaler) in Patients with COPD. Principal Site Investigator
– Dr. Darcy D. Marciniuk (Dr. John Reid is Site Co- Investigator). Boehringer Ingelheim Canada, May
2008 to April 2009, $101,352.50. NON-PEER REVIEWED

Effect of Inhalation of a Free Combination of Tiotropium Once Daily 18 mcg and Salmeterol Twice Daily
50 mcg Versus a Fixed Combination of Fluticasone and Salmeterol Twice Daily (500/50 mcg) on Static
Lung Volumes and Exercise Tolerance in COPD Patients (A Randomized, Double-Blind, Double Dummy,
16 [2 x 8] Weeks, Crossover Study). Principal Site Investigator - Dr. Darcy D. Marciniuk (Dr. John Reid
is Site Co-Investigator). Boehringer Ingelheim Canada, September 2007 to November 2008,
$91,888.50. NON-PEER REVIEWED

Reid JK:
Sleep Disordered Breathing and Pregnancy Induced Hypertension. Principal Investigator – Dr. John
Reid (Drs. F Olatunbosun, D. Cotton, R. Skomro, J. Gjevre, J. Gordon are Co-investigators). Royal
University Hospital Foundation Grant, 2008 to 2010, $25,000. PEER REVIEWED

Skomro RP:

Characterization of Sleep Disturbances in Rheumatoid Arthritis. Principal Site Investigator – Dr. R.
Taylor-Gjevre (Co-Investigators are Dr. J. Gjevre, B. Nair, R. Skomro). Royal University Hospital
Foundation Grant, May 2008, $18,000.00. PEER REVIEWED

Impact of wait times in patients with OSA not treated with CPAP. Principal Investigator – Dr. R.
Skomro (Co-Investigators Dr. J. Gjevre, C. Dehoney, C. Lee). Royal University Hospital Foundation
Grant, March 2007 to August 2008, $4500.00. PEER REVIEWED
VISITING PROFESSORSHIPS:

Marciniuk DD:

Division of Respirology, McMaster University, Hamilton, Ontario, April 28 and 29, 2008.

PROMOTION REVIEWS (EXTERNAL):

Marciniuk DD:

External Member, Promotion Review Committee (Promotion to Professor), Department of Medicine,
University of Manitoba, August 2007.
External Member, Promotion Review Committee (Promotion to Associate Professor), College of
Nursing, University of Saskatchewan, August 2007.

Reid JK:

External Member, Promotion Review Committee (Promotion to Professor), Department of Medicine,
University of Manitoba, September 2007.

MANUSCRIPT REVIEWS:

Cockcroft DW:
Chest (5), Journal of Allergy and Clinical Immunology (8), Annals of Allergy (8), Canadian Respiratory
Journal (4), Respiratory Medicine (4), American Journal of Respiratory and Critical Care Medicine (1),
Clinical Experimental Allergy (1), European Respiratory Journal (3), Others (4)

Gordon JR:
Primary reviewer, Journal of Immunology, Ad Hoc Reviewer, International Immunology
Marciniuk DD:
Chest (3), Canadian Respiratory Journal (2), Respiration (1)

Skomro RP:
Thorax (2), Canadian Respiratory Journal (3), Journal of Clinical Sleep Medicine (1), Brazilian Journal of
Medical and Biological Research (1)
TEACHING AND PROFESSIONAL LEARNING

UNDERGRADUATE TEACHING: (cumulative for the Division)
Respiratory Systems
Other Undergraduate Teaching

Professional
Clinical Sciences
JURSIs (# of clinical weeks supervised)
OSCE Examinations

(* time devoted to preparation, marking, student evaluations, course feedback, and mentoring are not
included in the above totals)
POSTGRADUATE TEACHING: (cumulative for the Division)
Residents (# of clinical weeks supervised)
Fellows (# of clinical weeks supervised)
Oral Examinations
Grand Rounds
Other Teaching ie. Outpatients, Seminars

(* time devoted to preparation, marking, individual student evaluations, course feedback, and
mentoring are not included in the above totals)
ADMINISTRATION ASSOCIATED WITH TEACHING:
Gjevre JA:

• Director, Saskatoon Cystic Fibrosis Clinic • Assistant Residency Program Director, Department of Medicine
Gordon JR:

• Head, Canadian Center for Health in Agriculture and Safety Hurst TS:


Marciniuk DD:

• Head, Division of Respirology, Critical Care and Sleep Medicine • Medical Director, Saskatoon Health Region Cardiopulmonary Exercise Testing Laboratory • Site Director, Royal University Hospital Intensive Care Unit • Program Director, Adult Respirology Fellowship Training Program
Skomro RP:

• Clinical Lead, Saskatoon Sleep Disorders Center • Assistant Residency Program Director, Department of Medicine
THESES SUPERVISED:

Cockcroft DW:

• PhD Supervisor – B. Davis (2004 to present). • MSc Committee Member – R. Chura (2007 to present)
Gordon JR:

o Adam Huys (BSc), summer student (2007) o Leanne Wist (Dept Micro & Immunol; Micro 491.6 honours project) o Dan Meyer (Dept Micro & Immunol; Micro 491.6 honours project) o Zach Freeman (Colorado State Univ), Meriel summer studentship (2008) o Sandeep Dhaliwal (BSc), summer student (2008) o DaveRishi Pahwa, NSERC summer studentship (2008) • Unscheduled graduate Student supervision: o Wei Li (Dept Immunology, Dalian Medical University), September 2006 to • Postgraduate Students Supervised, or on their Committee SOUGHT SUBJECT AREA
2007-2008 Committee Al-Dissi , Ahmad (DVM)
Marciniuk DD:

• Co-Supervisor, M.Sc. Advisory Committee, for Ms. Robyn Chura, 2007 to present. • Member, M.Sc. Advisory Committee for Ms. Cindy Wong, 2008 to present. • Member, M.Sc. Advisory Committee Ms. Shelly Hutchinson, 2008 to present. • Member, Ph.D. Advisory Committee for Ms. S. Kirychuk, 2003 to 2008. • Supervisor, Postgraduate Sleep and Transplant Medicine Fellowship Training, for Dr. Mark CLINICAL SERVICES AND ACTIVITY (Clinical Members Only)
Night Coverage (cumulative for 6 members taking night call)

Call Weeks (cumulative for the Division)
Clinical Exercise Laboratory (4 members)
Total Outpatient Visits (referral practices only)

Other Clinical Services provided by the Division include:
• In-Hospital, Emergency Room and Urgent Outpatient Consultation Service • 24-7 Telephone and Tier I Consultation Service • Supervision and Interpretation, Pulmonary Function Laboratory (RUH) • Sleep Laboratory Coverage and Call (six complete PSG/5 nights/week) • Cardiopulmonary Exercise Testing Laboratory Coverage • Complex Pulmonary Hypertension Clinic • Tuberculosis Clinics (initiated 2007 in conjunction with members of the Division of Tuberculosis Control with consolidation of the Provincial Tuberculosis Control Program with the Chronic Disease Management Program of the Saskatoon Health Region) ADMINISTRATION AND LEADERSHIP

PROFESSIONAL ACTIVITY WITHIN THE UNIVERSITY AND HEALTH REGION:

Cockcroft DW:

• Member, College of Medicine Accreditation Task Force, 2008 to date. • Member, Department of Community Health and Epidemiology Promotion Committee, 2007. • Member, Department of Medicine Salary Review Committee, 2006 to date. • “Airways” Respiratory Research Group, Founding and Acting Director, 2006 to date. • Chair, Department of Medicine Research Committee, 2007 to 2010.
Cotton DJ:

• Project Co-ordinator, Sleep Well Pilot Project, October 2006 to present.
Gjevre JA:

• Director, Adult Cystic Fibrosis Clinic, 2003 to present. • Assistant Program Director (Research), Internal Medicine Residency Program, Department • Member, College of Medicine, Research Ethics Committee, 2007 to present. • Member, Department of Medicine Residency Training Committee, 2007 to present. • Member, College of Medicine Faculty Council, 2003 to present. • Member, Respiratory Medicine Fellowship Training Program Committee, 2002 to present. • Member, Department of Medicine Finance Committee, 2004 to present.
Gordon JR:

• Mentor, Veterinary Medicine TriCouncil Task Force. • Chair, Executive Committee, Vaccinology and Immunotherapeutic Program CGSR. • Internal Reviewer, University of Saskatchewan TriCouncil Grant Applications. • Representative for the College of Medicine to the Faculty of Veterinary Medicine. • Member, School of Public Health Academic Programs Committee. • Member, School of Public Health Advisory Committee.
Graham BL:

• Member, Research Centre for the Elimination of Tuberculosis Steering Committee 1996- • President and CEO, Lung Association of Saskatchewan, 2002-present.
Hurst TS:

• Member, Animal Care/Facilities Committee, September 1999 to present. • Chair, Respiratory Medicine Barnett-Horlick Library Committee, 1994 to 2007. • Member, Phase B Curriculum Committee, 2007.
Laframboise KF:

• Medical Director, Pulmonary Function Laboratory, Royal University Hospital, January 2008 to • Director, Pulmonary Vascular Disease Program, Division of Respirology, Critical Care and Sleep • Member, Canadian Pulmonary Artery Hypertension Advisory Board, 2002 to present. • Member, Respiratory Training Committee, 1997 to present. • Member, ICU Management Committee, 1997 to present. • Member, ICU Billing Subcommittee, 1997 to present.
Marciniuk DD:

• Medical Director, University of Saskatchewan and Saskatoon Health Region Chronic Disease Management Program, July 2005 to present. • Member, Acute Care Consolidation Project – Observation and Telemetry, Saskatoon Health Region, • Member, Department of Medical Imaging Continuing Status and Renewal Committee, September • Co-Chair, Chronic Disease Management Operations Committee, Saskatoon Health Region, 2004 to • Member, Department of Medical Imaging Single Headship Appointments Committee, November • Member, Department of Medicine Executive Committee 2003 to present. • Medical Director, Saskatoon Pulmonary Rehabilitation Exercise Program, December 1994 to • Medical Director, Clinical Exercise Laboratory, October 1996 to present. • Member, Division of Respiratory Medicine Quality Assurance Committee, 1990 to present. • Member, Department of Medicine Respirology Residency Training Committee, 1990 to present. • Director, Respiratory, Critical Care and Sleep Medicine Fellowship Program, 2006 to • Review Committee for Assistant Dean of Undergraduate Education, 2008. • AFMC National Clinical Skills Working Group Evidence-Based Clinical Skills Document, 2008. • Department of Medicine Representative on College of Medicine Simulator-Based Education • ICU IV Add Mixtures Standardizing Practice Committee, 2008. • Member, Saskatoon Health Region Critical Care Realignment Planning Committee, March • Director, Medical School Clinical Sciences Phase B Course; Medicine Component, 2003 to • Director, Medical School Clinical Sciences Phase B Course Overall, 2005 to present. • Member of Division of Respiratory, Critical Care and Sleep Medicine, 2003 to present. • Site Director, RUH Adult Critical Care, 2006 to present. • Member of Saskatoon Health Region Department of Adult Critical Care, 2005 to present. • Member, College of Medicine Phase B/C Curriculum Sub-Committee, 2005 to present. • Member, College of Medicine Clinical Skills and Professionalism Sub-Committee, 2005 to • Member, College of Medicine Clinical Sciences Teaching Space Working Group, 2006 to • Member, Department of Medicine Executive Committee, 2003 to present. • Member, Department of Medicine Residency Training Committee, 2006 to present. • Member, Department of Medicine Education Committee, 2005 to present. • Member, Division of Respiratory, Critical Care and Sleep Medicine Residency Training
Skomro RP:

• Clinical Lead, Sleep Disorders Centre, July 2007 to present. • Member, College of Medicine Phase B/C Committee. • Member, Department of Medicine Education Committee, July 2007 to present. • Member, Respiratory Medicine Training Program Committee, 1998 to present. • Member, Department of Medicine Education Committee, July 2007 to present. CONSULTING WORK UNDERTAKEN:

Skomro RP:
American Board of Internal Medicine, Pulmonary Disease Section – Exam Questions Reviewer, 2004 to
2007.
PROFESSIONAL ACTIVITY OUTSIDE THE UNIVERSITY:

Cockcroft DW:

• Member, ERS Assembly 5: Inflammatory Airway Diseases and Clinical Allergy, 2004 to present. • Editorial Board, Annals of Allergy, Asthma and Clinical Immunology. • Member, AAAAI Asthma Diagnosis Committee, 2006 to present. • Fellow, American Academy of Allergy, Asthma and Immunology (AAAAI), 2006 to present. • Member, Scientific Advisory Committee on Respiratory and Allergy Therapies (SAC-RAT), Health • Editorial Board, Chest, 2006 to 2011. • Reviewer Board, Journal of Allergy and Clinical Immunology, 2006 to 2008. • Contributing Editor, Allergy, Asthma and Clinical Immunology (CSACI Journal), 2004 to present. • Member, CTS Asthma Committee, 1990 to present. • Canadian Upper Airway Guidelines Committee (CSACI), 2002 to present. • Chair, STS Standards & Policy Committee, 2000 to present. • Editorial Board, Asthma Today: A Practical Approach for Canadian Physicians, Parkhurst • Associate Editor, Canadian Respiratory Journal, 1993 to present. • International Advisory Board, Respiratory Medicine, 1991 to present. • Fellow, American College of Allergy and Immunology, 1990 to present. • Member, Canadian Society of Clinical Investigation, 1981 to present. • Member, Canadian Society of Allergy and Clinical Immunology, 1978 to present. • Member, Saskatchewan College of Physicians and Surgeons, 1977 to present. • Member, Saskatchewan Medical Association, 1977 to present. • Member, Canadian Thoracic Society, 1977 to present. • Member, American Thoracic Society, 1977 to present. • Member, Canadian Medical Association, 1976 to present.
Cotton DJ:

• Member, American Sleep Disorders Association, 1998 to present. • Member, Asian Pacific Society of Respirology, 1997 to present. • Member, Canadian Association of Professors of Medicine, 1994 to present. • Member, Saskatchewan Thoracic Society, 1991 to present. • Fellow, American College of Chest Physicians, 1981 to present. • Member, Canadian Society for Clinical Investigation, 1980 to present. • Member, American Physiological Society, 1980 to present. • Member, Canadian Thoracic Society, 1977 to present. • Member, American Thoracic Society, 1976 to present. • Member, Royal College of Physicians and Surgeons, 1976 to present. • Member, Proficiency Standards Committee, American Thoracic Society, 1984 to 1985; 2006 to • Canadian Thoracic Society, Life Member, 2005 to present.
Gjevre JA:

• President, Saskatchewan Thoracic Society, November 2007 to November 2008. • Chair, Educational Subcommittee, Annual Educational Meeting, Saskatchewan Thoracic Society, • Cystic Fibrosis Clinic Site Accreditor, Memorial University, St. John’s, Newfoundland, June 2008, • Member, Clinic Subcommittee, Canadian Cystic Fibrosis Foundation, 2005 to present. • Member, Executive Committee, Canadian Cystic Fibrosis Foundation, 2007 to present. • 2008 Abstract Reviewer, Cystic Fibrosis Section, Chest 2008, Annual International Meeting of the • Member, Executive Committee, Saskatchewan Thoracic Society, 2006 to present. • Member, Saskatoon Endoscopy Executive Committee, June 2005 to present. Gordon JR:

• Member, Board of Directors, Saskatchewan Health Research Foundation (SHRF), 2006 to 2009. • Chair, Saskatchewan Health Research Foundation Impact of Health Research in Saskatchewan • Member, Canadian Agricultural Safety Association Council, 2008 to present. • Member, Board of Directors, Agrivita Inc, 2007 to present. • Member, Scientific Advisory. Board, Pacgen Biopharmaceuticals Corp, Vancouver, British • Member, Canadian Cystic Fibrosis Foundation Medical/Scientific Advisory Board, 2006 to 2009. • Member, Canadian Allergy, Asthma and Immunology Foundation (CAAIF) Fellowship Review • Member, Society for Leukocyte Biology, 2007 to present. • Member, Canadian Society for Allergy and Clinical Immunology, 2007 to present. • Canadian Society for Immunology, 2007 to present. • Member, Collegium Internationale Allergologicum, 2008 to present.
Graham BL:

• Chair, Saskatchewan Home Respiratory Therapy Advisory Committee, 2008 to present. • Member, American Thoracic Society Proficiency Standards for Clinical Pulmonary Function Laboratories Committee, 2007 to present. • Chair – Chronic Diseases Working Group, Canadian Lung Association, 2006 to present. • Vice President, International Development, Canadian Lung Association, 1999 to 2007. • Member, Technical Advisory Committee on Home Respiratory Therapy, Saskatchewan Health, • Chair, Tuberculosis Working Group, Canadian Lung Association, 1998 to present. • Member, American Thoracic Society, 1986 to present. • Member, Canadian Thoracic Society, 1979 to present. • Member, Saskatchewan Thoracic Society, 1990 to present.
Laframboise KF:

• Saskatchewan Medical Association, Representative Assembly, March 2008 to present. • Physician Examiner, Medical Council of Canada, October 27th, 2007 (10.5 hrs). • Department of Adult Critical Care Committee, Saskatoon Health Region, 2006 to present. • Co-Chair, Saskatchewan Medical Association Intensive Care Unit Billing Committee. • Member, Saskatoon Endoscopy Executive Committee, June 2005 to present. • Member, Saskatchewan Thoracic Society Executive Committee. • Past President, Saskatchewan Thoracic Society, November 2006 to November 2007. Marciniuk DD:
• Member, CHEST Foundation Pro Bono Committee, American College of Chest Physicians, April • Member, Chief Executive Officer and Executive Vice President Search Committee, American College of Chest Physicians, March 2008 to present. • Member, Saskatchewan Medical Association Medical Compensation Review Committee, March • Member, Saskatchewan Home Respiratory Therapy Committee, January 2008 to present. • Abstract Review Committee, “Chest Infections, Obstructive Lung Diseases, Interstitial Lung Diseases, Pleural Diseases”. American College of Chest Physicians 2008 International Meeting, • Member (Presidential Appointee), Nominations Committee, American Col ege of Chest Physicians, • Member, CHEST Foundation Development Committee, October 2007 to present. • Member, CHEST Foundation Board of Trustees, American College of Chest Physicians, September • Member, Ex Officio, American College of Chest Physicians CHEST 2008 Scientific Program • Member, Executive Committee, American College of Chest Physicians International Nominations • Member, Annual Meeting Strategic Task Force, American College of Chest Physicians, July 2007 • Member, Scientific Steering Committee, Canadian Respiratory Congress, July 2007 to present. • Member, Organizing Committee, Canadian Respiratory Congress, July 2007 to present. • Member, Steering Committee, Public Health Agency of Canada National Lung Health Framework, • Member, National Chronic Disease Management Working Group (Directors and Medical Directors), Public Health Agency of Canada, February 2007 to present. • Member, National Grant Review Committee, Canadian Thoracic Society, January 2007 to present. • Member, American College of Chest Physicians Board of Regents, October 2006 to present. • Chair, Saskatchewan Respirology Summits, Saskatchewan Respirology Group and the Lung Association of Saskatchewan, October 2006 to present. • Member, American College of Chest Physicians International Strategy Ad Hoc Committee, October • Member, Canadian Lung Association Public Policy Committee, September 2006 to present. • Chair, Lung Association of Saskatchewan Medical Advisory Board, April 2006 to present. • Member, Lung Association of Saskatchewan Board of Directors, April 2006 to present. • Member. Canadian Cohort COPD Study Steering Committee, April 2005 to present. • Member, Expert Committee, Canadian COPDTrec Training Program, 2004 to present. • Member, Canadian Thoracic Society, Executive Committee, April 2004 to present. • Member, Canadian Lung Association BreathWorks Advisory Committee September 2002 to • Member, Canadian Thoracic Society COPD Rehabilitation Committee, March 2001 to present. • Member, Canadian Thoracic Society Executive COPD Guideline Committee, 2001 to present. • Member, American College of Chest Physicians. • Member, Saskatoon District Medical Society • Member, Saskatchewan Thoracic Society. • Member, American College of Chest Physicians. • President, Canadian Thoracic Society, October 2006 to November 2007. • Chair, RCPSC Examination Board Specialty Committee for Respiratory Medicine, July 2005 to • Member, Canadian Lung Association Board of Directors, October 2006 to November 2007. • Member, American College of Chest Physicians 2007 Annual Meeting Program Committee, • Member, American College of Chest Physicians International Nominations Subcommittee of the Nominations Committee, January 2006 to October 2007. • Member, American College of Chest Physicians Task Force on International Strategy, June 2006 • Abstract Reviewer, American College of Chest Physicians 2007 Annual Meeting: COPD, Exercise Physiology, Pulmonary Rehabilitation, Infections. • Member, American College of Chest Physicians International Nominations Committee, October • Member, Canadian Thoracic Society Breath Sounds Editorial Board, September 2002 to • Member, Royal College Subspecialty Training Committee for Respirology, 2006 to present. • Member, ICU IV Add Mixtures Standardizing Practice Committee, 2008 to present. • Member, Two-Site ICU Impact Assessment Clinical Practice Working Group, 2008. • Member, Committee for the Use of ‘BIPAP’, 2008 to present. • Member, ICU Self-Study Quality Assurance Survey, 2007 to present. • Member, Adult Critical Care Executive Committee, Saskatoon Health Region, 2006 to • Member, Adult Critical Care Operations Committee, Saskatoon Health Region, 2006 to • Member, Royal University Hospital Adult Critical Care Executive Committee, 2003 to • Member, Royal University Hospital Adult Critical Care Quality & Safety Collaborative • Member, Royal University Hospital Adult Critical Care Quality & Safety Collaborative Core • Member, Royal University Hospital Trauma Committee, 2006 to present. • ACLS Instructor, Office of Continuing Medical Education, 2003 to present.
Skomro RP:

• Co-Chair, Saskatchewan Sleep Disorders Task Force, 2006 to present. • Member, Canadian Thoracic Society Sleep Disorders Group. • Advisor, Saskatchewan Aids to Independent Living Program (SAIL). • Member, Royal College of Physicians and Surgeons of Canada Specialty Committee in Respirology Nucleus Group, 2002 to present. • Deputy Chair, Royal College of Physicians and Surgeons of Canada Specialty Committee in Respirology Nucleus Group, 2004 to present. • Member, International Committee, American Academy of Sleep Medicine, 2003 to 2006. • Member, Continuing Medical Education, American Academy of Sleep Medicine, 2006 to 2009. • Governor (Saskatchewan), American College of Chest Physicians, 2003 to 2007. • Treasurer, Saskatchewan Thoracic Society, 2004 to present. • Member, American Sleep Disorders Association. • Member, Canadian Medical Association. • Member, American College of Chest Physicians.
PUBLIC AND COMMUNITY SERVICE:
Cockcroft DW:

• 2007 CPLS Lily Show – July 19-21, 2007. Winner of Percy Wright Award “Best Red Lily Stem” AJ Porter Award “Best Canadian Hybrid” and TA (Andy) Dingwall Memorial Award for Asiatic Lily Collection.
Gordon JR:

• Market Prospects, Farm Gate (CTV), Health and Safety on Saskatchewan’s Farms (April 19, • Shaw TV, A new treatment for asthma (May 14, 2008). • Fundraising Member, Canadian Cystic Fibrosis Foundation. • “Sleepless in Saskatchewan” DVD Project. One hour and 15 minute videotaped interview for the Agricultural Health and Safety Network and Saskatchewan Ministry of Agriculture, May, 2008. Skomro RP:
• “Sleepless in Saskatchewan” DVD Project. One hour videotaped interview for the Agricultural Health and Safety Network and Saskatchewan Ministry of Agriculture, June 4, 2008. • “Sleep Laboratory”. Interview by Global TB, February 2008.

Source: https://www.medicine.usask.ca/medicine/divisions/respirology/ANNUAL%20REPORT%202007%20-%202008%20FINAL.pdf